Evidence map›Paper›PMID 42477186›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Identification of miR-21-5p and miR-21-3p regulated hub genes and drug repurposing targets in cervical cancer: an integrative computational analysis.

Muhammad Bilal Azmi, Rafia Wasi, Arisha Sohail, Uzma Asif

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Bilal AzmiComputational Biochemistry Research Laboratory, Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. bilal.azmi@duhs.edu.pk.ORCID http://orcid.org/0000-0001-8320-4479
Rafia Wasi *Computational Biochemistry Research Laboratory, Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Arisha Sohail *Computational Biochemistry Research Laboratory, Department of Biochemistry, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.ORCID http://orcid.org/0000-0001-5986-1786
Uzma AsifDepartment of Biochemistry, Medicine Program, Batterjee Medical College, Jeddah, Saudi Arabia.ORCID http://orcid.org/0000-0002-4659-9173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer remains a major cause of cancer-related mortality in women, and there is limited understanding of strand-specific miRNA regulation. This study investigated the differential regulatory roles of miR-21-5p and miR-21-3p and their associated gene networks using an integrative computational approach. A total of 664 experimentally validated targets for miR-21-5p and 3663 for miR-21-3p were identified, with 628 and 99 strand-specific targets, respectively, and five overlapping genes (SPRY1, STAT3, CLIP4, SMAD7, and PPARA). Expression analysis using TCGA-CESC data demonstrated consistent upregulation of miR-21 across all clinical subgroups, independent of age, stage, and histological subtypes. Protein-protein interaction analysis revealed a dense network for miR-21-5p (559 nodes, 3252 edges) compared to that for miR-21-3p (4 nodes, 133 edges), indicating a broader regulatory influence of the 5p strand. Five hub genes (TP53, PTEN, EGFR, STAT3, and CCND1) were identified, with PTEN and EGFR common to both strands. Differential expression analysis showed downregulation of PTEN and upregulation of CCND1, EGFR (p = 1.83 × 10⁻

Indexed as

Cervical cancerGene regulatory networksHub genes (PTEN, EGFR)miR-21-5p and miR-21-3pMolecular docking

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.